The organization and its wholly owned subsidiary, Polarean, Inc. (collectively the 'Group'), are generating revenue as companies specialized in medical imaging technology within the high-definition medical imaging sector. Through the exploration, creation, and introduction of innovative imaging solutions using a non-intrusive and radiation-free functional imaging platform, Polarean aims to assist in addressing the unmet medical requirements of over 500 million patients globally who suffer from chronic respiratory illness. Polarean is a pioneer in hyperpolarization science and has effectively produced the initial and sole hyperpolarized MRI contrast agent.